Targeted overexpression of androgen receptor in osteoblasts: Unexpected complex bone phenotype in growing animals

Endocrinology

Volumn 145, Issue 7, 2004, Pages 3507-3522

  Wiren, Kristine M ^a,b   Zhang, Xiao Wei ^a,b   Toombs, Amber R ^a   Kasparcova, Viera ^c   Gentile, Michael A ^c   Harada, Shun Ichi ^e   Jepsen, Karl J ^d  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e Portland Vet Aff Med C ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; COLLAGEN TYPE 1; DNA FRAGMENT; OSTEOCALCIN; OSTEOPROTEGERIN;

ANIMAL TISSUE; ARTICLE; BODY HEIGHT; BONE DEVELOPMENT; BONE GROWTH; BONE MINERAL; BONE STRENGTH; CONTROLLED STUDY; FEMALE; FEMUR; GENE OVEREXPRESSION; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR CLONING; MOLECULAR MECHANICS; NONHUMAN; OSTEOBLAST; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; RAT; SEX DIFFERENCE; TRABECULAR BONE; TRANSGENIC ANIMAL; WEIGHT GAIN;

ANIMALS; BONE DEVELOPMENT; COLLAGEN TYPE I; FEMALE; FEMUR; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MALE; MICE; MICE, INBRED STRAINS; MICE, TRANSGENIC; OSTEOBLASTS; PHENOTYPE; PREGNANCY; PROMOTER REGIONS (GENETICS); RATS; RECEPTORS, ANDROGEN; SEX CHARACTERISTICS;

EID: 3042541735     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-1016     Document Type: Article

References (60)

1. Cooper C, Melton LR 1996 Magnitude and impact of osteoporosis and fractures. In: Marcus R, Feldman D, Kelsey J, eds. Osteoporosis. San Diego: Academic Press; 419-434
2. Greenspan S, Oppenheim D, Klibanski A 1989 Importance of gonadal steroids to bone mass in men with hyperprolactinemic hypogonadism. Ann Intern Med 110:526-531
3. Turner R, Hannon K, Demers L, Buchanan J, Bell N 1989 Differential effects of gonadal function on bone histomorphometry in male and female rats. J Bone Miner Res 4:557-563
4. Miller B, De Souza M, Slade K, Luciano A 2000 Sublingual administration of micronized estradiol and progesterone, with and without micronized testosterone: effect on biochemical markers of bone metabolism and bone mineral density. Menopause 7:318-326
5. Castelo-Branco C, Vicente J, Figueras F, Sanjuan A, Martinez de Osaba M, Casals E, Pons F, Balasch J, Vanrell J 2000 Comparative effects of estrogens plus androgens and tibolone on bone, lipid pattern and sexuality in post-menopausal women. Maturitas 34:161-168
6. Raisz L, Wiita B, Artis A, Bowen A, Schwartz S, Trahiotis M, Shoukri K, Smith J 1996 Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in post-menopausal women. J Clin Endocrinol Metab 81:37-43
7. Kenny A, Raisz L 2002 Mechanisms of bone remodeling: implications for clinical practice. J Reprod Med 47:63-70
8. Liegibel U, Sommer U, Tomakidi P, Hilscher U, Van Den Heuvel L, Pirzer R, Hillmeier J, Nawroth P, Kasperk C 2002 Concerted action of androgens and mechanical strain shifts bone metabolism from high turnover into an osteo-anabolic mode. J Exp Med 196:1387-1392
9. Leder B, LeBlanc K, Schoenfeld D, Eastell R, Finkelstein J 2003 Differential effects of androgens and estrogens on bone turnover in normal men. J Clin Endocrinol Metab 88:204-210
10. Hamrick M, McPherron A, Lovejoy C, Hudson J 2000 Femoral morphology and cross-sectional geometry of adult myostatin-deficient mice. Bone 27:343-349
11. Reid I 2002 Relationships among body mass, its components, and bone. Bone 31:547-555
12. Kousteni S, Bellido T, Plotkin L, O'Brien C, Bodenner D, Han L, Han K, DiGregorio G, Katzenellenbogen J, Katzenellenbogen B, Roberson P, Weinstein R, Jilka R, Manolagas S 2001 Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 104:719-730
13. Kousteni S, Chen J, Bellido T, Han L, Ali A, O'Brien C, Plotkin L, Fu Q, Mancino A, Wen Y, Vertino A, Powers C, Stewart S, Ebert R, Parfitt A, Weinstein R, Jilka R, Manolagas S 2002 Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Science 298:843-846
14. van der Eerden B, Emons J, Ahmed S, van Essen H, Lowik C, Wit J, Karperien M 2002 Evidence for genomic and nongenomic actions of estrogen in growth plate regulation in female and male rats at the onset of sexual maturation. J Endocrinol 175:277-288
15. Sims N, Clement-Lacroix P, Minet D, Fraslon-Vanhulle C, Gaillard-Kelly M, Resche-Rigon M, Baron R 2003 A functional androgen receptor is not sufficient to allow estradiol to protect bone after gonadectomy in estradiol receptor-deficient mice. J Clin Invest 111:1319-1327
16. Kawano H, Sato T, Yamada T, Matsumoto T, Sekine K, Watanabe T, Nakamura T, Fukuda T, Yoshimura K, Yoshizawa T, Aihara K, Yamamoto Y, Nakamichi Y, Metzger D, Chambon P, Nakamura K, Kawaguchi H, Kato S 2003 Suppressive function of androgen receptor in bone resorption. Proc Natl Acad Sci USA 100:9416-9421
17. Yeh S, Tsai M, Xu Q, Mu X, Lardy H, Huang K, Lin H, Yeh S, Altuwaijri S, Zhou X, Xing L, Boyce B, Hung M, Zhang S, Gan L, Chang C, Hung M 2002 Generation and characterization of androgen receptor knockout (ARKO) mice: an in vivo model for the study of androgen functions in selective tissues. Proc Natl Acad Sci USA 99:13498-13503
18. Vanderschueren D, Van Herck E, Suiker A, Visser W, Schot L, Chung K, Lucas R, Einhorn T, Bouillon R 1993 Bone and mineral metabolism in the androgen-resistant (testicular feminized) male rat. J Bone Miner Res 8:801-809
19. Wakley G, Schutte H, Hannon K, Turner R 1991 Androgen treatment prevents loss of cancellous bone in the orchidectomized rat. J Bone Miner Res 6:325-330
20. Seeman E 2001 Sexual dimorphism in skeletal size, density, and strength. J Clin Endocrinol Metab 86:4576-4584
21. Winer J, Jung C, Shackel I, Williams P 1999 Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem 270:41-49
22. Ding M, Odgaard A, Hvid I 1999 Accuracy of cancellous bone volume fraction measured by micro-CT scanning. J Biomech 32:323-326
23. Jepsen K, Goldstein S, Kuhn J, Schaffler M, Bonadio J 1996 Type I collagen mutation compromises the post-yield behavior of Mov13 long bone. J Orthoped Res 14:493-499
24. Baker J 1958 Principles of biological microtechnique. New York: John Wiley, Sons, Inc.
25. Aaron J, Johnson D, Kanis J, Oakley B, O'Higgins P, Paxton S 1992 An automated method for the analysis of trabecular bone structure. Comput Biomed Res 25:1-16
26. Parfitt A, Drezner M, Glorieux F, Kanis J, Malluche H, Meunier P, Ott S, Recker R 1987 Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595-610
27. Jepsen K, Pennington D, Lee Y-L, Warman M, Nadeau J 2001 Bone brittleness varies with genetic background in A/J and C57BL/6J inbred mice. J Bone Miner Res 16:1854-1862
28. Harrison J, Kleinert L, Kelly P, Krebsbach P, Woody C, Clark S, Rowe D, Lichtler A, Kream B 1998 Interleukin-1 represses COLIA1 promoter activity in calvarial bones of transgenic ColCAT mice in vitro and in vivo. J Bone Miner Res 13:1076-1083
29. Kalajzic I, Kalajzic Z, Kaliterna M, Gronowicz G, Clark S, Lichtler A, Rowe D 2002 Use of type I collagen green fluorescent protein transgenes to identify subpopulations of cells at different stages of the osteoblast lineage. J Bone Miner Res 17:15-25
30. Watanabe H, Suzuki A, Kobayashi M, Takahashi E, Itamoto M, Lubahn D, Handa H, Iguchi T 2003 Analysis of temporal changes in the expression of estrogen-regulated genes in the uterus. J Mol Endocrinol 30:347-358
31. Woitge H, Harrison J, Ivkosic A, Krozowski Z, Kream B 2001 Cloning and in vitro characterization of α 1(I)-collagen 11 β-hydroxysteroid dehydrogenase type 2 transgenes as models for osteoblast-selective inactivation of natural glucocorticoid. Endocrinology 142:1341-1348
32. Kalajzic Z, Liu P, Kalajzic I, Du Z, Braut A, Mina M, Canalis E, Rowe D 2002 Directing the expression of a green fluorescent protein transgene in differentiated osteoblasts: comparison between rat type I collagen and rat osteocalcin promoters. Bone 31:654-660
33. Bedalov A, Salvatori R, Dodig M, Kapural B, Pavlin D, Kream B, Clark S, Woody C, Rowe D, Lichtler A 1998 1,25-Dihydroxyvitamin D3 inhibition of col1a1 promoter expression in calvariae from neonatal transgenic mice. Biochim Biophys Acta 1398:285-293
34. Dacquin R, Starbuck M, Schinke T, Karsenty G 2002 Mouse α1(I)-collagen promoter is the best known promoter to drive efficient Cre recombinase expression in osteoblast. Dev Dyn 224:245-251
35. Marcus R 2000 Anabolic therapies. Clin Lab Med 20:623-637
36. Negro-Vilar A 1999 Selective androgen receptor modulators (SARMs): a novel approach to androgen therapy for the new millennium. J Clin Endocrinol Metab 84:3459-3462
37. Jordan V 2003 Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 2. Clinical considerations and new agents. J Med Chem:1081-1111
38. Rauch F, Travers R, Plotkin H, Glorieux F 2002 The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta. J Clin Invest 110:1293-1299
39. McCarthy E, Raggio C, Hossack M, Miller E, Jain S, Boskey A, Camacho N 2002 Alendronate treatment for infants with osteogenesis imperfecta: demonstration of efficacy in a mouse model. Pediatr Res 52:660-670
40. Schenk R, Eggli P, Fleisch H, Rosini S 1986 Quantitative morphometric evaluation of the inhibitory activity of new aminobisphosphonates on bone resorption in the rat. Calcif Tissue Int 38:342-349
41. Vandenput L, Boonen S, Van Herck E, Swinnen J, Bouillon R, Vanderschueren D 2002 Evidence from the aged orchidectomized male rat model that 17β-estradiol is a more effective bone-sparing and anabolic agent than 5α-dihydrotestosterone. J Bone Miner Res 17:2080-2086
42. Mason R, Morris H 1997 Effects of dihydrotestosterone on bone biochemical markers in sham and oophorectomized rats. J Bone Miner Res 12:1431-1437
43. Lepola V, Hannuniemi R, Kippo K, Lauren L, Jalovaara P, Vaananen H 1996 Long-term effects of clodronate on growing rat bone. Bone 18:191-196
44. Seibel M 2000 Molecular markers of bone turnover: biochemical, technical and analytical aspects. Osteoporos Int 11(Suppl 6):S18-S29
45. Szulc P, Hofbauer L, Heufelder A, Roth S, Delmas P 2001 Osteoprotegerin serum levels in men: correlation with age, estrogen, and testosterone status. J Clin Endocrinol Metab 86:3162-3165
46. Hofbauer L, Hicok K, Chen D, Khosla S 2002 Regulation of osteoprotegerin production by androgens and anti-androgens in human osteoblastic lineage cells. Eur J Endocrinol 147:269-273
47. Khosla S, Atkinson E, Dunstan C, O'Fallon W 2002 Effect of estrogen versus testosterone on circulating osteoprotegerin and other cytokine levels in normal elderly men. J Clin Endocrinol Metab 87:1550-1554
48. Pederson L, Kremer M, Judd J, Pascoe D, Spelsberg T, Riggs B, Oursler M 1999 Androgens regulate bone resorption activity of isolated osteoclasts in vitro. Proc Natl Acad Sci USA 96:505-510
49. Chen Q, Kaji H, Sugimoto T, Chihara K 2001 Testosterone inhibits osteoclast formation stimulated by parathyroid hormone through androgen receptor. FEBS Lett 491:91-93
50. Bellido T, Jilka R, Boyce B, Girasole G, Broxmeyer H, Dalrymple S, Murray R, Manolagas S 1995 Regulation of interleukin-6, osteodastogenesis, and bone mass by androgens. J Clin Invest 95:2886-2895
51. Yanase T, Suzuki S, Goto K, Nomura M, Okabe T, Takayanagi R, Nawata H 2003 Aromatase in bone: roles of vitamin D(3) and androgens. J Steroid Biochem Mol Biol 86:393-397
52. Falahati-Nini A, Riggs B, Atkinson E, O'Fallon W, Eastell R, Khosla S 2000 Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest 106:1553-3560
53. Vanderschueren D, Vandenput L 2000 Androgens and osteoporosis. Andrologia 32:125-130
54. Moverare S, Venken K, Eriksson A, Andersson N, Skrtic S, Wergedal J, Mohan S, Salmon P, Bouillon R, Gustafsson J, Vanderschueren D, Ohlsson C 2003 Differential effects on bone of estrogen receptor α and androgen receptor activation in orchidectomized adult male mice. Proc Natl Acad Sci USA 100:13573-13578
55. Jepsen K, Akkus O, Majeska R, Nadeau J 2003 Hierarchical relationship between bone traits and mechanical properties in inbred mice. Mamm Genome 14:97-104
56. Jepsen K, Schaffler M, Kuhn J, Goulet R, Bonadio J, Goldstein S 1997 Type I collagen mutation alters the strength and fatigue behavior of Mov13 cortical tissue. J Biomech 30:1141-1147
57. Phillip M, Maor G, Assa S, Silbergeld A, Segev Y 2001 Testosterone stimulates growth of tibial epiphyseal growth plate and insulin-like growth factor-1 receptor abundance in hypophysectomized and castrated rats. Endocrine 16:1-6
58. Wiren K, Chapman Evans A, Zhang X 2002 Osteoblast differentiation influences androgen and estrogen receptor-α and -β expression. J Endocrinol 175:683-694
59. Takeuchi M, Kakushi H, Tohkin M 1994 Androgens directly stimulate mineralization and increase androgen receptors in human osteoblast-like osteosarcoma cells. Biochem Biophys Res Commun 204:905-911
60. Vandenput L, Swinnen J, Van Herck E, Verstuyf A, Boonen S, Bouillon R, Vanderschueren D 2002 The estrogen receptor ligand ICI 182,780 does not impair the bone-sparing effects of testosterone in the young orchidectomized rat model. Calcif Tissue Int 70:170-175